Screener
Pulse Biosciences, Inc. PLSE Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Pulse Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The source filing: Pulse Biosciences, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:23 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-026288
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Accounts payable | $2,832 | $2,777 |
| Accrued liabilities | 6,460 | 3,576 |
| Lease liability, current | 1,686 | 1,570 |
| Total current liabilities | 10,978 | 7,923 |
| Lease liability, less current portion | 5,086 | 5,960 |
| Total liabilities | 16,064 | 13,883 |
| Stockholders’ equity: | ||
| Preferred stock, $0.001 par value; authorized – 50,000,000 shares; no shares issued and outstanding | — | — |
Document
FAQ
- What is Pulse Biosciences, Inc.'s total current liabilities?
- Pulse Biosciences, Inc. (PLSE) reported total current liabilities of $10.98M in Q2 2026.
- How has Pulse Biosciences, Inc.'s total current liabilities changed year-over-year?
- Pulse Biosciences, Inc.'s total current liabilities increased by 22.3% year-over-year, from $8.98M to $10.98M.
- What is the long-term trend for Pulse Biosciences, Inc.'s total current liabilities?
- Over 5 years (2020 to 2025), Pulse Biosciences, Inc.'s total current liabilities has grown at a 0.9% compound annual growth rate (CAGR), from $7.59M to $7.92M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.
Ask your AI about Pulse Biosciences, Inc.'s total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude